Stroke: New Developments and Their Application in Clinical Practice

Peter J. Kelly; Eoin Kavanagh; Sean Murphy

doi:10.1055/s-0036-1586261

Seminars in Neurology, Table of Contents

Semin Neurol 2016; 36(04): 317-323
DOI: 10.1055/s-0036-1586261

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Stroke: New Developments and Their Application in Clinical Practice

Peter J. Kelly

¹Department of Neurology, Mater Misericordiae University Hospital, Dublin, Ireland

,

Eoin Kavanagh

²Department of Radiology, Mater Misericordiae University Hospital, Dublin, Ireland

,

Sean Murphy

³Department of Stroke Medicine, Mater Misericordiae University Hospital, Dublin, Ireland

› Author Affiliations

Abstract

Significant advances have been made in recent years in primary stroke prevention, improved stroke outcomes in high-income populations, emergency stroke therapy, and stroke prevention. In this article, we review recent trends in stroke epidemiology, improvements in delivery of intravenous thrombolysis (via stroke system-wide approaches, application of ‘Lean Principles’ to improve workflow processes, and re-evaluation of exclusion criteria), recent stroke thrombectomy trials, and new developments in stroke prevention, with emphasis on risk prediction in transient ischemic attack, choice and timing of anticoagulation therapy for secondary stroke prevention, and emerging concepts in risk stratification for management of symptomatic carotid stenosis.

Keywords

stroke - population - therapy - atrial fibrillation - transient ischaemic attack - prevention

Full Text

References

References
1 Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013; 34 (39) 3028-3034
2 Mozaffarian D, Benjamin EJ, Go AS , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 2015; 131 (4) e29-e322
3 Koton S, Schneider AL, Rosamond WD , et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 2014; 312 (3) 259-268
4 Rosengren A, Giang KW, Lappas G, Jern C, Torén K, Björck L. Twenty-four-year trends in the incidence of ischemic stroke in Sweden from 1987 to 2010. Stroke 2013; 44 (9) 2388-2393
5 Feigin VL, Forouzanfar MH, Krishnamurthi R , et al; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014; 383 (9913) 245-254
6 Chugh SS, Havmoeller R, Narayanan K , et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129 (8) 837-847
7 Go AS, Hylek EM, Phillips KA , et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285 (18) 2370-2375
8 Bogiatzi C, Hackam DG, McLeod AI, Spence JD. Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 2014; 45 (11) 3208-3213
9 Béjot Y, Ben Salem D, Osseby GV , et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Neurology 2009; 72 (4) 346-353
10 Miyasaka Y, Barnes ME, Gersh BJ , et al. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study. Stroke 2005; 36 (11) 2362-2366
11 Fonarow GC, Smith EE, Saver JL , et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke 2011; 42 (10) 2983-2989
12 Fonarow GC, Zhao X, Smith EE , et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014; 311 (16) 1632-1640
13 Ford AL, Williams JA, Spencer M , et al. Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis. Stroke 2012; 43 (12) 3395-3398
14 Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 2012; 79 (4) 306-313
15 Meretoja A, Weir L, Ugalde M , et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology 2013; 81 (12) 1071-1076
16 Hacke W, Kaste M, Bluhmki E , et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 (13) 1317-1329
17 Emberson J, Lees KR, Lyden P , et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014; 384 (9958) 1929-1935
18 Demaerschalk BM, Kleindorfer DO, Adeoye OM , et al; American Heart Association Stroke Council and Council on Epidemiology and Prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2016; 47 (2) 581-641
19 Demchuk AM, Menon BK, Goyal M. Comparing vessel imaging; non-contrast computed tomography/computed tomography angiography should be the new minimum standard in acute disabling stroke. Stroke 2016; 47 (1) 273-281
20 Cheng-Ching E, Frontera JA, Man S , et al. Degree of collaterals and not time is the determining factor of core infarct volume within 6 hours of stroke onset. AJNR Am J Neuroradiol 2015; 36 (7) 1272-1276
21 Yeo LLL, Paliwal P, Teoh HL , et al. Assessment of intracranial collaterals on CT angiography in anterior circulation acute ischemic stroke. AJNR Am J Neuroradiol 2015; 36 (2) 289-294
22 Saarinen JT, Rusanen H, Sillanpää N. Collateral score complements clot location in predicting the outcome of intravenous thrombolysis. AJNR Am J Neuroradiol 2014; 35 (10) 1892-1896
23 Menon BK, d'Esterre CD, Qazi EM , et al. Multiphase CT angiography: a new tool for the imaging of patients with acute ischemic stroke. Radiology 2015; 275 (2) 510-520
24 Berkhemer OA, Fransen PSS, Beumer D , et al; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372 (1) 11-20
25 Campbell BCV, Mitchell PJ, Kleinig TJ , et al; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372 (11) 1009-1018
26 Goyal M, Demchuk AM, Menon BK , et al; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372 (11) 1019-1030
27 Saver JL, Goyal M, Bonafe A , et al; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372 (24) 2285-2295
28 Jovin TG, Chamorro A, Cobo E , et al; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372 (24) 2296-2306
29 Touma L, Filion KB, Sterling LH, Atallah R, Windle SB, Eisenberg MJ. Stent retrievers for the treatment of acute ischemic stroke. A systematic review and meta-analysis of randomised controlled trials. JAMA Neurol 2016; 73 (3) 275-281
30 Smith EE, Schwamm LH. Endovascular clot retrieval therapy: implications for the organization of stroke systems of care in North America. Stroke 2015; 46 (6) 1462-1467
31 Tatlisumak T. Implication of the recent positive endovascular intervention trials for organizing acute stroke care: European perspective. Stroke 2015; 46 (6) 1468-1473
32 Toyoda K, Koga M, Hayakawa M, Yamagami H. Acute reperfusion therapy and stroke care in Asia after successful endovascular trials. Stroke 2015; 46 (6) 1474-1481
33 Ganesalingam J, Pizzo E, Morris S, Sunderland T, Ames D, Lobotesis K. Cost-utility analysis of mechanical thrombectomy using stent retrievers in acute ischemic stroke. Stroke 2015; 46 (9) 2591-2598
34 Leppert MH, Campbell JD, Simpson JR, Burke JF. Cost-effectiveness of intra-arterial treatment as an adjunct to intravenous tissue-type plasminogen activator for acute ischemic stroke. Stroke 2015; 46 (7) 1870-1876
35 Prabhakaran S, Chong JY, Sacco RL. Impact of abnormal diffusion-weighted imaging results on short-term outcome following transient ischemic attack. Arch Neurol 2007; 64 (8) 1105-1109
36 Ay H, Arsava EM, Johnston SC , et al. Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2009; 40 (1) 181-186
37 Coutts SB, Simon JE, Eliasziw M , et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005; 57 (6) 848-854
38 Johnston SC, Rothwell PM, Nguyen-Huynh MN , et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369 (9558) 283-292
39 Merwick A, Albers GW, Amarenco P , et al. Addition of brain and carotid imaging to the ABCD� score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol 2010; 9 (11) 1060-1069
40 Pessin MS, Estol CJ, Lafranchise F, Caplan LR. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993; 43 (7) 1298-1303
41 Connolly SJ, Ezekowitz MD, Yusuf S , et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361 (12) 1139-1151
42 Patel MR, Mahaffey KW, Garg J , et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365 (10) 883-891
43 Granger CB, Alexander JH, McMurray JJ , et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365 (11) 981-992
44 Giugliano RP, Ruff CT, Braunwald E , et al; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369 (22) 2093-2104
45 Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJM ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363 (9413) 915-924
46 Johansson E, Cuadrado-Godia E, Hayden D , et al. Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: A pooled analysis. Neurology 2016; 86 (6) 498-504
47 Ringleb PA, Bousser MG, Ford G , et al, for the The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 . Available at: http://www.eso-stroke.org/ . Accessed January 30, 2015
48 Furie KL, Kasner SE, Adams RJ , et al; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 (1) 227-276
49 Strömberg S, Gelin J, Osterberg T, Bergström GM, Karlström L, Osterberg K ; Swedish Vascular Registry (Swedvasc) Steering Committee. Very urgent carotid endarterectomy confers increased procedural risk. Stroke 2012; 43 (5) 1331-1335
50 Saam T, Hetterich H, Hoffmann V , et al. Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging. J Am Coll Cardiol 2013; 62 (12) 1081-1091
51 Marnane M, Merwick A, Sheehan OC , et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 2012; 71 (5) 709-718